1.
Augustin M, Wegtowska J, Lebwohl M, Paul C, Piguet V, Sofen H, Blauvelt A, Peterson L, Arendt C, Rolleri R. Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study. J of Skin [Internet]. 2018Dec.17 [cited 2024Jul.22];2:S86. Available from: https://jofskin.org/index.php/skin/article/view/483